|
Volumn 5, Issue 2, 1998, Pages 80-83
|
What type of travelers would benefit from combined vaccination against hepatitis A and B?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS A ANTIBODY;
HEPATITIS A VACCINE;
HEPATITIS B VACCINE;
ARTICLE;
COST EFFECTIVENESS ANALYSIS;
DEVELOPING COUNTRY;
HEPATITIS A;
HEPATITIS B;
HUMAN;
INCIDENCE;
INDUSTRIALIZATION;
INFECTION RISK;
RISK FACTOR;
SEXUAL BEHAVIOR;
TRAVEL;
VACCINATION;
COST-BENEFIT ANALYSIS;
HEPATITIS A;
HEPATITIS B;
HEPATITIS B VACCINES;
HUMANS;
RISK FACTORS;
SEXUALLY TRANSMITTED DISEASES;
TRAVEL;
VACCINES, COMBINED;
VIRAL HEPATITIS VACCINES;
|
EID: 0031799371
PISSN: 11951982
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1708-8305.1998.tb00468.x Document Type: Article |
Times cited : (14)
|
References (10)
|